E89.89Other postprocedural endocrine and metabolic complications and disorders

E89.89 is the ICD-10-CM diagnosis code for other postprocedural endocrine and metabolic complications and disorders. It belongs to category E89 (postprocedural endocrine and metabolic complications and disorders, not elsewhere classified), block E89 (postprocedural endocrine and metabolic complications and disorders, not elsewhere classified) and chapter 4 (endocrine, nutritional and metabolic diseases). It is billable, so it can be reported on its own for dates of service from October 1, 2026 through September 30, 2027.

Within E89.8, choose E89.89 (Other postprocedural endocrine and metabolic complications and disorders) only when documentation doesn't support a more specific option: postprocedural hemorrhage of an endocrine system organ or structure following a procedure (E89.81), postprocedural hematoma and seroma of an endocrine system organ or structure (E89.82) and postprocedural hypoglycemia following a procedure (E89.83).

Use an additional code, if applicable, to further specify disorder.

As a secondary diagnosis it is a CC (complication or comorbidity), which can move an inpatient stay into the "with CC" MS-DRG of its family, unless the principal diagnosis excludes it.

In MS-DRG v44.0, it is part of the grouping logic for DRG 919 (Complications of Treatment with MCC, relative weight 1.763), DRG 920 (Complications of Treatment with CC, relative weight 0.9975) and DRG 921 (Complications of Treatment without CC/MCC, relative weight 0.6722), in MDC 21 (Injuries, Poisonings and Toxic Effects of Drugs), as a principal or secondary diagnosis. The DRG a claim lands in depends on the principal diagnosis, procedures and any CC/MCC secondary diagnoses.

It has been part of ICD-10-CM since the code set took effect on October 1, 2015 and hasn't changed since.

Before ICD-10, this condition was coded in ICD-9-CM as 997.99 (complications affecting other specified body systems, not elsewhere classified).